
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Vote in favor of your favored spot to peruse - 2
5 things for parents to know about changes to kids vaccine schedule - 3
Mom warns of Christmas gift hazard as daughter recovers in hospital - 4
EU chief urges Iran to free imprisoned protesters, lift internet ban - 5
Timex Gives Its Classic Affordable Field Watch a Tactical, Milspec Makeover
Holiday season sees uptick in norovirus cases, according to CDC
'No middle ground' for tackling antisemitism after Bondi Beach mass shooting, deputy FM Haskel says
2 new malaria treatments announced as drug resistance grows
Four countries to boycott Eurovision 2026 over Israel’s inclusion
21 Things You Ought to Never Share with Your Childless Companion
Golden satellite insulation sparkles during test | Space photo of the day for Dec. 30, 2025
7 Espresso Machines for Home Baristas
The most effective method to Refresh the Infotainment Framework in the Volvo XC40
Figuring out the Business venture Code: The Response to Building an Effective Startup













